Print this page    •   Back to Web version of article

The Body Covers: The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment

The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment
Buenos Aires, Argentina

July 8-11, 2001

The Body Covers:
The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment
Buenos Aires, Argentina

July 8-11, 2001


The International AIDS Society has been coordinating the International AIDS Conferences every two years. Because science has been advancing so fast and such an overwhelming amount of progress has been seen, they have decided to add another conference in the years when the International AIDS conference is not held. This new event will be smaller and devoted to basic and clinical science. Scientists from around the world are expected to meet to present and discuss their data formatted in two tracks: basic science (co-chairs: David Ho, USA and Horacio Salomon, Argentina) and clinical science (co-chairs: Julio Montaner, Canada and Carlos Zala, Argentina).

Reporting exclusively for The Body are Calvin J. Cohen, M.D., M.S.; Andrew T. Pavia, M.D.; Douglas T. Dieterich, M.D.; Howard Grossman, M.D.; Brian A. Boyle, M.D., J.D.; Pablo Tebas, M.D.; Alvan Fisher, M.D.; and Robert J. Frascino, M.D. For more information on these outstanding doctors, click on their pictures or on their names.

Click here for a look at the program.

Funding for this conference coverage at The Body is provided, in part, by unrestricted educational grants from Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, and Ortho Biotech, Inc.


The Body's Conference Summaries
Day One
Sunday,
July 8
Day Two
Monday,
July 9
Day Three
Tuesday,
July 10
Day Four
Wednesday,
July 11
Learning Basic Science from Clinical Trials

Current Controversies in Antiretroviral Therapy and Potential Solutions: Translating Science into Action

Fostering Access to HIV/AIDS Care and Treatment

Clinical Trials

Viral Reservoirs

Treatment Strategies

Liver Diseases and HIV

Update On Resistance

Pharmacological Issues in ARV Therapy

Antiretroviral Therapy I

New Antiviral Drugs

Cost Benefit and Outcomes of HAART

Pharmacology

Invited Lecture

Plenary Lectures

Antiretroviral Therapy

Toxicities of HAART

Therapies Directly Targeting the Immune System

Salvage Therapy

IAS-USA Panel

Antiretroviral Therapy II

Lipodystrophy

Hyperlactatemia and Other Toxicities

Resistance

Plenary Lectures

Invited Lecture

Current Controversies in Immuno Pathogenesis


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement




This article was provided by TheBodyPRO.com. Copyright Body Health Resources Corporation. All rights reserved.

You can find this article online by typing the following address into your Web browser:
http://www.thebody.com/content/art15984.html

Please Note: Knowledge about HIV changes rapidly. Note the date of this article's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this article.

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your healthcare provider.